Nektar Therapeutics
NKTR
NKTR
177 hedge funds and large institutions have $1.91B invested in Nektar Therapeutics in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 66 increasing their positions, 63 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
177
Holders Change
+1
Holders Change %
+0.57%
% of All Funds
4.73%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.13%
New
20
Increased
66
Reduced
63
Closed
18
Calls
$3.22M
Puts
$2.6M
Net Calls
+$624K
Net Calls Change
-$189K
Top Buyers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$17.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.29M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$3.39M |
| 4 |
PC
PointState Capital
New York
|
+$2.85M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.73M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$25.6M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$25.2M |
| 3 |
AG
Artal Group
Luxembourg
|
-$8.54M |
| 4 |
D.E. Shaw & Co
New York
|
-$8.2M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$4.07M |
